1. Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants.
- Author
-
Yuan H, Mitchell CW, Ferenbach AT, Bonati MT, Feresin A, Benke PJ, Tan QKG, and van Aalten DMF
- Subjects
- Animals, Mice, Humans, Acetylglucosamine metabolism, Mouse Embryonic Stem Cells metabolism, Glycosylation, Congenital Disorders of Glycosylation genetics, Congenital Disorders of Glycosylation metabolism, Mutation, Missense, N-Acetylglucosaminyltransferases metabolism, N-Acetylglucosaminyltransferases genetics, Intellectual Disability genetics, Intellectual Disability metabolism, Homeostasis
- Abstract
O-GlcNAcylation is an essential protein modification catalyzed by O-GlcNAc transferase (OGT). Missense variants in OGT are linked to a novel intellectual disability syndrome known as OGT congenital disorder of glycosylation (OGT-CDG). The mechanisms by which OGT missense variants lead to this heterogeneous syndrome are not understood, and no unified method exists for dissecting pathogenic from non-pathogenic variants. Here, we develop a double-fluorescence strategy in mouse embryonic stem cells to measure disruption of O-GlcNAc homeostasis by quantifying the effects of variants on endogenous OGT expression. OGT-CDG variants generally elicited a lower feedback response than wild-type and Genome Aggregation Database (gnomAD) OGT variants. This approach was then used to dissect new putative OGT-CDG variants from pathogenic background variants in other disease-associated genes. Our work enables the prediction of pathogenicity for rapidly emerging de novo OGT-CDG variants and points to reduced disruption of O-GlcNAc homeostasis as a common mechanism underpinning OGT-CDG., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF